Lactation Induced
2
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
2
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Medica CorpGalatonol 300 mg/Striatin 30 mg
Human BioSciencesFemaltiker
Clinical Trials (2)
Total enrollment: 269 patients across 2 trials
Supplementation of Galatonol 300 mg / Striatin 30 mg in Postpartum Lactating Mothers
Start: Oct 2024Est. completion: May 2025160 patients
Phase 3Completed
Effectiveness of Femaltiker in Stimulation Lactation Among Mothers of Preterm Infants
Start: Apr 2014Est. completion: Nov 2015109 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 late-stage (Phase 3) programs, potential near-term approvals
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.